Reply: idiopathic pulmonary fibrosis: perspectives on clinically meaningful primary endpoints in phase 3 clinical trials.

Journal Article (Letter)

Full Text

Duke Authors

Anstrom, Kevin J.

Cited Authors

Raghu, G; Collard, HR; Anstrom, KJ; Flaherty, KR; Fleming, TR; King, TE; Martinez, FJ; Brown, KK

Published Date

June 1, 2013

Published In

American Journal of Respiratory and Critical Care Medicine

Volume / Issue

187 / 11

Start / End Page

1272 -

PubMed ID

23725623

Electronic International Standard Serial Number (EISSN)

1535-4970

Digital Object Identifier (DOI)

10.1164/rccm.201304-0712LE

Language

eng

Conference Location

United States